Navigation Links
Cell Transplantation study investigates fate and function of cells transplanted to the CNS

Putnam Valley, NY. (Dec. 20, 2012) When different types of cells are transplanted with the intent of having them aid in repairing central nervous system (CNS) trauma, what is the fate and function of those cells? A Belgian research team carried out research aimed at answering this question by determining how five varieties of cells - neural stem cells, mouse embryonic fibroblasts, dendritic cells, bone marrow mononuclear cells (BMMNCs) and splenocytes - functioned and survived after transplantation in the CNS.

Their study is published in a recent issue of Cell Transplantation (21:9), now freely available on-line at

"Severe injuries to the central nervous system due to trauma are among the top five causes of death and represent a significant social and economic health burden on society," said Dr. Peter Ponsaerts of the University of Antwerp. "There are no currently effective treatments to restore damaged or dysfunctional neural tissues, although much progress is expected to come from stem cell research."

Their research investigated how factors such as cell migration, cell graft survival, cell graft immunogenicity and cell graft toxicity are impacted two weeks post-transplantation. Their study examined the fate and function of the five varieties of cells mentioned above after they were transplanted into the CNS of transgenic mice, both healthy and those modeled with CNS injury with subsequent inflammation.

"We did not see a significant increase for any cell types in cell migration under inflammatory conditions when compared to healthy conditions," said the authors. "With regard to cell graft survival, to our surprise, only a few of the cells were able to survive under both healthy and inflammatory conditions."

However, they found "striking differences" in how endogenous immune responses against grafted cells were organized. They speculated that differences were due to both the degree of microglia and astrocyte invasion. Responses of both were observed in each different cell variety. BMMNC and splenocyte grafts were less invaded by microglia, but displayed high levels of astrocyte invasion.

Finally, with regard to cell graft toxicity, the researchers found that "none of the cell populations could directly contribute to remyelination." They speculated that two weeks might not be sufficient time for proper differentiation of grafted NSCs, although endogenous remyelination does occur within a two-week time period.

"Our results warrant further research to better understand and eventually control cell graft induced tissue damage and activation of the brain's innate immune system," they wrote.


Contact: Robert Miranda
Cell Transplantation Center of Excellence for Aging and Brain Repair

Related biology news :

1. Cell Transplantation reports islet cell advancement increases impact on transplantation
2. Neurons made from stem cells drive brain activity after transplantation in laboratory model
3. Studies in Cell Transplantation investigate oxygens impact as a factor in transplantation
4. New studies show spinal cord injury and ALS respond to cell transplantation
5. Stem cell transplantation into mouse cochlea may impact future hearing loss therapies
6. Some factors that impact islet transplantation explored in Cell Transplantation papers
7. Some factors that impact islet transplantation explored in Cell Transplantation papers
8. 2 Cell Transplantation studies impact dental stem cell research for therapeutic purposes
9. Gut microbiota transplantation may prevent development of diabetes and fatty liver disease
10. Study reports iron oxide nanoparticles effective for labeling human endothelial cells
11. Study looks at gray seal impact on beach water quality
Post Your Comments:
(Date:5/20/2016)... 20, 2016  VoiceIt is excited to announce ... By working together, VoiceIt and VoicePass ... and VoicePass take slightly different approaches to voice ... security and usability. ... new partnership. "This marketing and technology ...
(Date:4/28/2016)... and BANGALORE, India , April 28, ... Systems, a product subsidiary of Infosys (NYSE: INFY ... announced a global partnership that will provide end ... use mobile banking and payment services.      (Logo: ... key innovation area for financial services, but it also plays ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... , June 23, 2016 ... Review, 2016;12(1):22-8 Published ... the peer-reviewed journal from touchONCOLOGY, Andrew D ... cost of cancer care is placing an increasing ... of expensive biologic therapies. With the patents on ...
(Date:6/23/2016)... Francisco, CA (PRWEB) , ... June 23, 2016 ... ... (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase its ... Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a division ... tuned and optimized exclusively for Okuma CNC machining centers at The International Manufacturing ... collaboration among several companies with expertise in toolholding, cutting tools, machining dynamics and ...
Breaking Biology Technology: